Advisory Board and Editors Cardiology
Huashan Shi
Professor Shi Huashan is an Associate Professor at Sichuan University. His expertise is in the molecular biology of tumours and tumour transcriptomics. He is currently engaged in clinical and basic translational research, including tumour microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumour cell vaccines.
Jeremy A. Simpson
Assistant Professor, University of Guelph. Editorial board, Frontiers in Respiratory Physiology
Edward R Smith
Professor Edward Smith is an Associate Professor in the Department of Medicine, University of Melbourne and Senior Scientist at the Kincaid-Smith Renal Laboratories, Department of Nephrology, The Royal Melbourne Hospital. He is interested in mineral metabolism and kidney disease.
Dinesh C Voruganti
Dr. Dinesh Voruganti is a Cardiology Fellow at the University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. He is a clinical cardiology fellow with focussed interest in clinical research. Dr. Voruganti's expertise involves database based research.
Shibiao Wan
Dr. Shibiao Wan is currently an Assistant Professor in the Department of Genetics, Cell Biology and Anatomy, and the Co-Director for the Bioinformatics and Systems Biology (BISB) PhD Program at University of Nebraska Medical Center (UNMC). He is also an Assistant Professor (courtesy) in the Department of Biostatistics at UNMC.
With more than 15 years of experience in machine learning, bioinformatics, and computational biology, Dr. Wan has published >50 articles in top-tiered journals such as Genome Research, Nature Communications, Science Advances, Circulation Research, Briefings in Bioinformatics, and Bioinformatics. Dr. Wan is the Editor-in-Chief for Current Proteomics, and an Editorial Board Member for a series of prestigious journals such as Briefings in Functional Genomics, Heliyon, BMC Bioinformatics, International Journal of Microbiology, PeerJ Computer Science, BioMed Research International, and Computational and Mathematical Methods, and a guest associate editor for multiple high-impact journals including Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Frontiers in Pharmacology, Biology, Frontiers in Genetics, and Genes.
Dr Wan is a TPC member for >20 machine learning related international conferences including IEEE ICTAI. Dr. Wan is also a reviewer for >70 prestigious journals including Nature Biotechnology, Nature Methods, Nature Communications, Nature Computational Science, Science Advances, Nucleic Acids Research, Advanced Science, Cancer Research, Genome Biology, and Genome Medicine. Dr. Wan has received a number of accolades including the Springer Nature Editor of Distinction Award in 2025 by Springer Nature, the New Investigator Award in 2024 by UNMC, the FIRST Award in 2023 by Nebraska EPSCoR, the Outstanding Young Alumni Award in 2022 by HK PolyU as well as the Global Peer Review Awards (top 1%) in “Cross-Field” and “Biology and Biochemistry” in 2019 by Clarivate. Dr. Wan is a member of AACR, ISCB and ACM and an IEEE Senior Member.
Bernhard Wernly
Dr Bernhard Wernly is a Physician-scientist at the Paracelsus Medical University, Salzberg, Austria. He is trained in cardiology and intensive care medicine, MD, PhD and currently doing a Master in Public Health.
Joseph C Wu
Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute and Simon H. Stertzer Professor of Medicine (Cardiology) and Radiology at the Stanford School of Medicine. Dr. Wu received his MD from Yale University School of Medicine. He trained in internal medicine and cardiology at UCLA followed by a PhD in the Dept of Molecular Pharmacology. His clinical interests involve cardiovascular imaging and adult congenital heart disease. His lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells (iPSCs). The main goals are to (i) understand basic cardiovascular disease mechanisms, (ii) accelerate drug discovery and screening, (iii) develop “clinical trial in a dish” concept, and (iv) implement precision cardiovascular medicine for prevention and treatment of patients. His lab uses a combination of genomics, stem cells, cellular & molecular biology, physiological testing, and molecular imaging technologies to better understand molecular and pathophysiological processes.
Lai-Hua Xie
Associate Professor at Rutgers-New Jersey Medical School, Editor of American Journal of Medical and Biological Research, Dataset Papers in Biology, Frontiers in Physiology, Journal of Cardiovascular Disease Research, PLOS One, World Journal Of Hypertension, and World Journal of Cardiology.
Wei Yang
Researcher at Bloodworks Research Institute and UW Medicine, University of Washington. Current work mainly focuses on zwitterionic-based surface coatings for long-term biomedical applications.
Guangdong Yang
Dr. Yang’s research focuses on a group of gasotransmitters, especially H2S, in the regulation of cellular functions and human diseases. Dr. Yang has received numerous awards and recognitions, including New Investigator award from the Heart and Stroke Foundation of Canada and Maureen Andrew Award from Heart and Stroke Foundation of Ontario. In his career, Dr. Yang has published ~100 peer-reviewed research articles, some of them published in high-impact journals, including as Science, Circulation, PNAS, and EMBO report etc. Their total citations are 7,481 (September 24, 2018).
Li Zuo
Fellow of the American College of Sports Medicine (FACSM) at The Ohio State University, College of Medicine.